Injectable Composition And Use Of Said Composition
Patent No. EP4232106 (titled "Injectable Composition And Use Of Said Composition") was filed by Innate on Oct 25, 2021. The application was issued on Feb 12, 2025.
Patent Summary
Injectable hydrogel composition comprising water, high molecular weight hyaluronic acid, and nicotinamide, which inhibits hyaluronidase activity to prolong the duration of the hyaluronic acid in the body. The composition is suitable for intra-articular and intradermal applications, including viscosupplementation and skin rejuvenation, and can be used in conjunction with platelet-rich plasma therapy.
Patent Family
Patent Oppositions (2)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP4232106
- Application Number
- EP21807254A
- Filing Date
- Oct 25, 2021
- Status
- Granted And Under Opposition
- Jan 10, 2025
- Publication Date
- Feb 12, 2025
- External Links
- Slate, Register , Google Patents